Nitric oxide inhibits the degradation of IRP2

Molecular and Cellular Biology

Volumn 25, Issue 4, 2005, Pages 1347-1353

  Wang, Jian ^a   Chen, Guohua ^a   Pantopoulos, Kostas ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; DEFEROXAMINE; GAMMA INTERFERON; HEMAGGLUTININ; IRON REGULATORY PROTEIN 2; LIPOPOLYSACCHARIDE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; PROLINE;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DIFFUSION; FIBROBLAST; HUMAN; HYPOXIA; IRON DEFICIENCY; IRON METABOLISM; LUNG CANCER; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ANIMALS; DEFEROXAMINE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IRON; IRON REGULATORY PROTEIN 2; MICE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PENICILLAMINE; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN DENATURATION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 13444252613     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.4.1347-1353.2005     Document Type: Article

References (29)

1. Bourdon, E., D. K. Kang, M. C. Ghosh, S. K. Drake, J. Wey, R. L. Levine, and T. A. Rouault. 2003. The role of endogenous heme synthesis and degradation domain cysteines in cellular iron-dependent degradation of IRP2. Blood Cells Mol. Dis. 31:247-255.
2. Bouton, C., L. Oliveira, and J.-C. Drapier. 1998. Converse modulation of IRP-1 and IRP-2 by immunological stimuli in murine RAW 264.7 macrophages. J. Biol. Chem. 273:9403-9408.
3. Chen, X., L. J. Ko, L. Jayaraman, and C. Prives. 1996. p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10:2438-2451.
4. Drapier, J. C., C. Pellat, and Y. Henry. 1991. Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells cocultured with activated macrophages. J. Biol. Chem. 266:10162-10167.
5. Feelisch, M. 1991. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous NO solutions. J. Cardiovasc. Pharmacol. 17(Suppl. 3):S25-S33.
6. Giaccia, A. J., and M. B. Kastan. 1998. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:2973-2983.
7. Glockzin, S., A. von Knethen, M. Scheffner, and B. Brune. 1999. Activation of the cell death program by nitric oxide involves inhibition of the proteasome. J. Biol. Chem. 274:19581-19586.
8. Guo, B., J. D. Phillips, Y. Yu, and E. A. Leibold. 1995. Iron regulates the intracellular degradation of iron regulatory protein 2 by the proteasome. J. Biol. Chem. 270:21645-21651.
9. Haile, D. J., T. A. Rouault, C. K. Tang, J. Chin, J. B. Harford, and R. D. Klausner. 1992. Reciprocal control of RNA-binding and aconitase activity in the regulation of the iron-responsive element binding protein: role of the iron-sulfur cluster. Proc. Natl. Acad. Sci. USA 89:7536-7540.
10. Hanson, E. S., M. L. Rawlins, and E. A. Leibold. 2003. Oxygen and iron regulation of iron regulatory protein 2. J. Biol. Chem. 278:40337-40342.
11. Hentze, M. W., M. U. Muckenthaler, and N. C. Andrews. 2004. Balancing acts; molecular control of mammalian iron metabolism. Cell 117:285-297.
12. Ignarro, L. J., H. Lippton, J. C. Edwards, W. H. Baricos, A. L. Hyman, P. J. Kadowitz, and C. A. Gruetter. 1981. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218:739-749.
13. Iwai, K., R. D. Klausner, and T. A. Rouault. 1995. Requirements for iron-regulated degradation of the RNA binding protein, iron regulatory protein 2. EMBO J. 14:5350-5357.
14. Kakhlon, O., and Z. I. Cabantchik. 2002. The labile iron pool: characterization, measurement, and participation in cellular processes. Free Radic. Biol. Med. 33:1037-1046.
15. Kim, S., and P. Ponka. 1999. Control of transferrin receptor expression via nitric oxide-mediated modulation of iron-regulatory protein 2. J. Biol. Chem. 274:33035-33042.
16. Kim, S., and P. Ponka. 2000. Effects of interferon-gamma and lipopolysaccharide on macrophage iron metabolism are mediated by nitric oxide-induced degradation of iron regulatory protein 2. J. Biol. Chem. 275:6220-6226.
17. Kim, S., and P. Ponka. 2002. Nitrogen monoxide-mediated control of ferritin synthesis: implications for macrophage iron homeostasis. Proc. Natl. Acad. Sci. USA 99:12214-12219.
18. Kim, S., S. S. Wing, and P. Ponka. 2004. S-nitrosylation of IRP2 regulates its stability via the ubiquitin-proteasome pathway. Mol. Cell. Biol. 24:330-337.
19. LaVaute, T., S. Smith, S. Cooperman, K. Iwai, W. Land, E. Meyron-Holtz, S. K. Drake, G. Miller, M. Abu-Asab, M. Tsokos, R. Switzer III, A. Grinberg, P. Love, N. Tresser, and T. A. Rouault. 2001. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27:209-214.
20. Meyron-Holtz, E. G., M. C. Ghosh, K. Iwai, T. LaVaute, X. Brazzolotto, U. V. Berger, W. Land, H. Ollivierre-Wilson, A. Grinberg, P. Love, and T. A. Rouault. 2004. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 23:386-395.
21. Pantopoulos, K. 2004. Iron metabolism and the IRE/IRP regulatory system: an update. Ann. N. Y. Acad. Sci. 1012:1-13.
22. Pantopoulos, K., and M. W. Hentze. 1995. Nitric oxide signaling to iron-regulatory protein (IRP): direct control of ferritin mRNA translation and transferrin receptor mRNA stability in transfected fibroblasts. Proc. Natl. Acad. Sci. USA 92:1267-1271.
23. Pantopoulos, K., and M. W. Hentze. 2000. Nitric oxide, oxygen radicals and iron metabolism, p. 293-313. In L. Ignarro (ed.), Nitric oxide. Academic Press, San Diego, Calif.
24. 2) control mammalian iron metabolism by different pathways. Mol. Cell. Biol. 16:3781-3788.
25. Phillips, J. D., D. V. Kinikini, Y. Yu, B. Guo, and E. A. Leibold. 1996. Differential regulation of IRP-1 and IRP-2 by nitric oxide in rat hepatoma cells. Blood 87:2983-2992.
26. Recalcati, S., D. Taramelli, D. Conte, and G. Cairo. 1998. Nitric oxide-mediated induction of ferritin synthesis in J774 macrophages by inflammatory cytokines: role of selective iron regulatory protein-2 downregulation. Blood 91:1059-1066.
27. Wang, J., G. Chen, M. Muckenthaler, B. Galy, M. W. Hentze, and K. Pantopoulos. 2004. Iron-mediated degradation of IRP2: an unexpected pathway involving a 2-oxoglutarate-dependent oxygenase activity. Mol. Cell. Biol. 24:954-965.
28. Weiss, G., B. Goossen, W. Doppler, D. Fuchs, K. Pantopoulos, G. Werner-Felmayer, H. Wachter, and M. W. Hentze. 1993. Translational regulation via iron-responsive elements by the nitric oxide/NO-synthase pathway. EMBO J. 12:3651-3657.
29. Yamanaka, K., H. Ishikawa, Y. Megumi, F. Tokunaga, M. Kanie, T. A. Rouault, I. Morishima, N. Minato, K. Ishimori, and K. Iwai. 2003. Identification of the ubiquitin-protein ligase that recognizes oxidized IRP2. Nat. Cell Biol. 5:336-340.